Non-ADAMTS13 Parameters Could Benefit Differential Diagnosis

Including biomarkers for non-ADAMTS13 in routine clinical testing could benefit diagnosis and follow-up in patients with immune-mediated thrombotic thrombocytopenic purpura (TTP).

Related Keywords

United Kingdom , , Adamts13 , Littp , Plasma , Antigen , Non Adamts13 ,